간행물

대한류마티스학회> Journal of Rheumatic Diseases(구 대한류마티스학회지)

Journal of Rheumatic Diseases(구 대한류마티스학회지) update

  • : 대한류마티스학회
  • : 의약학분야  >  정형외과학
  • : KCI등재
  • :
  • : 연속간행물
  • : 계간
  • : 2093-940X
  • : 2233-4718
  • : 대한류마티스학회지(~2010) → journal of rheumatic diseases(2011~)

수록정보
수록범위 : 1권1호(1994)~27권3호(2020) |수록논문 수 : 1,355
Journal of Rheumatic Diseases(구 대한류마티스학회지)
27권3호(2020년 07월) 수록논문
최근 권호 논문
| | | |

KCI등재

1The Role of Immunoglobulin G4 in Patients With Rheumatoid Arthritis

저자 : Jun-ki Min

발행기관 : 대한류마티스학회 간행물 : Journal of Rheumatic Diseases(구 대한류마티스학회지) 27권 3호 발행 연도 : 2020 페이지 : pp. 125-127 (3 pages)

다운로드

(기관인증 필요)

키워드 보기
초록보기

KCI등재

2Mechanism-based Drug Therapy of Inflammatory Bowel Disease With Special Reference to Rheumatic Disease

저자 : Jae Jun Park

발행기관 : 대한류마티스학회 간행물 : Journal of Rheumatic Diseases(구 대한류마티스학회지) 27권 3호 발행 연도 : 2020 페이지 : pp. 128-135 (8 pages)

다운로드

(기관인증 필요)

초록보기

Inflammatory bowel disease (IBD), comprised of Crohn's disease and ulcerative colitis, is a chronic, relapsing, and remitting disease of the gastrointestinal tract whose incidence is rising worldwide, especially in East Asian countries. The etiopathogenesis of IBD remains poorly understood. It is currently considered that a combination of genetic and environmental factors triggers an aberrant immune response against the commensal intestinal flora in IBD patients. Over the past decades, advances in the knowledge of the inflammatory cascade involved in IBD pathogenesis have expanded the pharmacological armamentarium in IBD. Actually, the introduction of specific biological therapies, including anti- tumor necrosis factor, anti-interleukin- 12/23, and anti-integrin, has revolutionized the treatment of IBD. Moreover, small molecule agents such as Janus kinase inhibitors also now under clinical use. In IBD, a substantial number of patient accompanies various articular manifestations and, rheumatic involvement is one of the most common extra-intestinal symptoms. Many of the mechanisms based drugs described above have already been used in rheumatic diseases. In addition, some of those drugs can be used to treat both IBD itself and accompanied rheumatic involvement, however there are differences in drug usage between these two indications. This review aims to briefly review the mechanism-based drug therapies of IBD with particular reference to rheumatic disease. (J Rheum Dis 2020;27:128-135)

KCI등재

3Utility of Magnetic Resonance Imaging and Positron Emission Tomography in Rheumatic Diseases

저자 : Eun Hye Park , Chong-hyeon Yoon , Eun Ha Kang , Han Joo Baek

발행기관 : 대한류마티스학회 간행물 : Journal of Rheumatic Diseases(구 대한류마티스학회지) 27권 3호 발행 연도 : 2020 페이지 : pp. 136-151 (16 pages)

다운로드

(기관인증 필요)

초록보기

The use of magnetic resonance imaging (MRI) and positron emission tomography (PET) in rheumatology allows a better understanding of the pathophysiology of the disease as well as early diagnosis and appropriate evaluation of the disease status and treatment responses. Despite the limited availability because of the high cost, there is growing evidence for the advantages and clinical application of these modalities to various rheumatic diseases. This review discusses the basic mechanisms and clinical applications of MRI and PET in certain rheumatic diseases, including rheumatoid arthritis, axial spondyloarthritis, idiopathic inflammatory myopathies, large vessel vasculitis, central nervous system disease associated with rheumatic diseases, polymyalgia rheumatica, adult-onset Still's disease, and immunoglobulin G4-related disease. (J Rheum Dis 2020;27:136-151)

다운로드

(기관인증 필요)

초록보기

Objective. To assess the circulating levels of interleukin (IL)-37 in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), and determine a correlation between plasma/serum IL-37 levels and disease activity. Methods. We performed a meta-analysis comparing plasma/serum IL-37 level between patients with RA or SLE and controls, and examined correlation coefficients between circulating IL-37 levels and disease activity. Results. A total of 14 publications included 711 patients with RA and 394 controls, 522 patients with SLE and 259 controls. In the RA group, the IL-37 level was significantly higher than in the control group (standardized mean difference [SMD]=1.222, 95% confidence interval [CI]=0.722∼1.711, p<0.001). Subgroup analysis by sample size showed a significantly higher IL-37 level in RA group of large (n>90) and small sample numbers (n≤90) (SMD=0.994, 95% CI=0.323∼1.666, p<0.001; SMD=1.617, 95% CI=1.328∼1.906, p<0.001). In addition, IL-37 level in SLE group was significantly higher than in control group (SMD=1.096, 95% CI=0.635∼1.558, p<0.001). A strong association between circulating IL-37-level and RA activity based on Disease activity Score 28 was shown (correlation coefficients=0.547, 95% CI=0.355∼0.695, p<0.001). Meta-analysis of the coefficients for correlation indicated a positive correlation between the circulating level of IL-37 and SLE activity based on Systemic Lupus Erythematosus Disease Activity Index (coefficients for correlation<0.588, 95 % CI=0.270∼0.806, p=0.003). Conclusion. Our meta-analysis showed that circulating IL-37 levels are higher in RA and SLE patients, and there is a positive correlation between IL-37 and disease activity in RA and SLE. (J Rheum Dis 2020;27:152-158)

다운로드

(기관인증 필요)

초록보기

Objective. To investigate the impact of the amendment of the Korean National Health Insurance (KNHI) reimbursement criteria for anti-tumor necrosis factor-α (TNF-α) agents based on from conventional clinical and laboratory measurements to disease activity score of 28 joints (DAS28) on treatment pattern, clinical response, and persistence rate in patients with rheumatoid arthritis (RA). Methods. This multicenter retrospective cohort study evaluated 148 RA patients eligible for the initiation of anti- TNF-α agents as the first-line biologics by either the past (n=95) or current (n=53) KNHI reimbursement criteria. Persistence was defined as the duration between the initiation and discontinuation of anti-TNFα agents. Results. In total, 106 (71.6%), 35 (23.6%), and 7 (4.7%) RA patients started treatment with adalimumab, etanercept, and infliximab, respectively. RA patients who received anti-TNF-α agents under the current reimbursement criteria had a significantly lower mean DAS28-erythrocyte sedimentation rate (ESR) (6.02 vs. 6.95, p<0.001) and daily prednisolone-equivalent glucocorticoid dose (4.51 vs. 6.17 mg, p<0.001) than those who received anti-TNF-α agents under the past reimbursement criteria. No significant differences in the 1-year remission rate defined by DAS28-ESR<2.6 (17.9% vs. 30.2%, p=0.085) and the persistence rate (p=0.703) between the past and current reimbursement criteria was observed. Conclusion. Our data suggest that less active RA patients can receive reimbursement for anti-TNF-α agents under the current criteria, and the amendment of the KNHI reimbursement criteria may improve access to anti-TNF-α agents without affecting the treatment response and persistence rate. (J Rheum Dis 2020;27:159-167)

KCI등재

6Analysis of Asian Mitochondrial DNA Haplogroups Associated With the Progression of Knee Osteoarthritis in Koreans

저자 : Bon San Koo , Yoonah Song , Seunghun Lee , Yoon-kyoung Sung , Kyoung-jin Shin , Nam H. Cho , Jae-bum Jun

발행기관 : 대한류마티스학회 간행물 : Journal of Rheumatic Diseases(구 대한류마티스학회지) 27권 3호 발행 연도 : 2020 페이지 : pp. 168-173 (6 pages)

다운로드

(기관인증 필요)

초록보기

Objective. We investigated Asian mitochondrial DNA (mtDNA) haplogroups associated with knee osteoarthritis (OA) progression in a prospective community-based cohort comprised of Koreans. Methods. Epidemiologic data and Kellgren-Lawrence (K/L) scores of knee radiographs were obtained from the second (2005∼2006) and sixth (2013∼2014) follow-up, and patient DNA was analyzed. The mtDNA haplogroup frequencies (M, G, D, D4, D5, M7, M8, M9, M10, N, A, N9, R, F, and B) were compared between the progression (K/L score change on either knee ≥2 or arthroplasty) and non-progression (K/L score change on both knee ≤1) groups at the sixth follow-up. Multiple logistic regression was performed to determine relative risk (RRs) of mtDNA haplogroups for OA. Results. In total, 1,115 participants were included, 405 of whom had early OA (higher K/L score on both knees of 1 or 2). Among them, 143 and 166 patients were classified in non-progression and progression groups, respectively, at the sixth follow-up. The most frequent haplogroups, B and D4, in Koreans also showed a high frequency in our study. There were no significantly different haplogroups between the non-progression and progression groups. However, the frequency of haplogroup D4 was likely higher in the non-progression g	roup than in the progression group, although not significantly (13.3% vs. 7.2%, RR=0.51, p=0.081 in the unadjusted model and RR=0.56, p=0.149 in the adjusted model). Conclusion. No significant haplogroups are related to OA progression. Large-scaled studies are needed to reveal the association between mtDNA haplogroups and OA. (J Rheum Dis 2020;27:168-173)

KCI등재

7Trends of Gout Prevalence in South Korea Based on Medical Utilization: A National Health Insurance Service Database (2002∼2015)

저자 : Jin Su Park , Minjin Kang , Jung-soo Song , Hyun Sun Lim , Chan Hee Lee

발행기관 : 대한류마티스학회 간행물 : Journal of Rheumatic Diseases(구 대한류마티스학회지) 27권 3호 발행 연도 : 2020 페이지 : pp. 174-181 (8 pages)

다운로드

(기관인증 필요)

초록보기

Objective. Although gout is the most common form of inflammatory arthritis, data on gout prevalence and management are sparse, especially in Korean populations. This study reevaluated the most recent prevalence and incidence of gout values in Korean people to update the findings from our previous study in 2011. Methods. We used the National Health Insurance Service-National Health Information Database (NHIS-NHID) to identify patients diagnosed with gout in South Korea during 2002∼2015. We selected patients with gout as principal diagnosis or 1st∼4th additional diagnosis. Results. The prevalence of gout increased 5.17-fold, from 0.39% in 2002 to 2.01% in 2015. This increase occurred in all age groups, but was stronger in those aged 80 years or older, with a 13.1-fold increase from 2002 to 2015. The prevalence of gout increased in all regions of South Korea. The prevalence of the disease was also related to income levels: in 2015, medical insurance subscribers with the highest income were twice more likely to have gout than those in the lowest income bracket. By contrast, the prevalence of gout in medical benefit recipients was 5.58- and 5.25-times higher than that of the general population and of those in the highest income bracket, respectively. Conclusion. The prevalence of gout has increased rapidly, although the degree of increase varied according to sex, age, region, and income group. This study sheds some light on the current prevalence of gout among national insurance subscribers in Korea, and will help educate patients and medical staff on the management of gout. (J Rheum Dis 2020;27:174-181)

KCI등재

8The Practice Guideline for Vaccinating Korean Patients With Autoimmune Inflammatory Rheumatic Disease

저자 : Yu Bin Seo , Su-jin Moon , Chan Hong Jeon , Joon Young Song , Yoon-kyoung Sung , Su Jin Jeong , Ki Tae Kwon , Eu Suk Kim , Jae-hoon Kim , Hyoun-ah Kim , Dong-jin Park , Sung-hoon Park , Jin Kyun Park ,

발행기관 : 대한류마티스학회 간행물 : Journal of Rheumatic Diseases(구 대한류마티스학회지) 27권 3호 발행 연도 : 2020 페이지 : pp. 182-202 (21 pages)

다운로드

(기관인증 필요)

초록보기

To develop a clinical practice guideline for vaccination in patients with autoimmune inflammatory rheumatic disease (AIIRD), the Korean College of Rheumatology and the Korean Society of Infectious Diseases developed a clinical practice guideline according to the clinical practice guideline development manual. Since vaccination is unlikely to cause AIIRD or worsen disease activities, required vaccinations are recommended. Once patients are diagnosed with AIIRD, treatment strategies should be established and, at the same time, monitor their vaccination history. It is recommended to administer vaccines when the disease enters the stabilized stage. Administering live attenuated vaccines in patients with AIIRD who are taking immunosuppressants should be avoided. Vaccination should be considered in patients with AIIRD, prior to initiating immunosuppressants. It is recommended to administer influenza, Streptococcus pneumoniae, hepatitis A, hepatitis B, herpes zoster, measles-mumps-rubella virus, human papillomavirus, and tetanus-diphtheria-pertussis vaccines in patients with AIIRD; such patients who planned to travel are generally recommended to be vaccinated at the recommended vaccine level of healthy adults. Those who live in a household with patients with AIIRD and their caregivers should also be vaccinated at levels that are generally recommended for healthy adults. (J Rheum Dis 2020;27:182-202)

KCI등재

9Antineutrophil Cytoplasmic Antibodies Negative Microscopic Polyangiitis With Initial Pulmonary Manifestation

저자 : Jeong Seon Lee , Min Su Oh , Jin-haeng Chung , Soyoung Lee , Ji-won Kwon

발행기관 : 대한류마티스학회 간행물 : Journal of Rheumatic Diseases(구 대한류마티스학회지) 27권 3호 발행 연도 : 2020 페이지 : pp. 203-208 (6 pages)

다운로드

(기관인증 필요)

초록보기

Microscopic polyangiitis (MPA) is a small vessel vasculitides mostly associated with anti-neutrophil cytoplasmic antibodies (ANCA). The kidney is the most commonly affected organ in MPA. We report the case of a 9-year-old girl with ANCA-negative MPA who initially presented with respiratory symptoms, including cough, sputum, and dyspnea. Based on her symptoms, atypical pneumonia was suspected. Also, childhood interstitial lung disease was considered based on findings seen on chest CT. Despite initial improvement of symptoms with oral corticosteroid therapy, dyspnea with initiation of corticosteroid tapering was noted. A final diagnosis of MPA was made after lung biopsy. ANCA was negative in both the initial and repeat blood tests. Oral cyclophosphamide and prednisolone treatments led to full remission. Since then, the patient has been treated with low dose prednisolone and azathioprine for maintenance. A good treatment response was achieved and her clinical symptoms, pulmonary functions, and radiologic findings have since improved. Thus, early and precise diagnosis of MPA is crucial for remission induction and prevention of symptom relapse. (J Rheum Dis 2020;27:203-208)

KCI등재

10Bertolotti's Syndrome Requiring Intervention for Lower Back Pain: Two Cases Suspected as Ankylosing Spondylitis

저자 : Juyeon Kang , Seunghun Lee , Tae-hwan Kim

발행기관 : 대한류마티스학회 간행물 : Journal of Rheumatic Diseases(구 대한류마티스학회지) 27권 3호 발행 연도 : 2020 페이지 : pp. 209-212 (4 pages)

다운로드

(기관인증 필요)

초록보기

Bertolotti's syndrome is the part of lumbosacral transitional vertebra and is a congenital anomaly of the axial spine. The syndrome is associated with changes in the sacrum or iliac crest and secondary arthritis and is often mistaken for ankylosing spondylitis (AS). The mechanism of pain in this disease is unclear, and treatments have not been accurately established. Here, we report two cases of Bertolotti's syndrome in patients with severe back pain who were initially suspected to have AS and required interventional procedures. The two young adult patients developed symptoms similar to those of inflammatory back pain, and their symptoms did not improve with conventional treatment alone. Both patients underwent interventional management, and the symptoms improved. It may be clinically helpful to confirm the presence of Bertolotti's syndrome in patients with suspected AS, and interventional therapy may be required in some cases. (J Rheum Dis 2020;27:209-212)

12
권호별 보기
가장 많이 인용된 논문

(자료제공: 네이버학술정보)

가장 많이 인용된 논문
| | | |
1연안해역에서 석유오염물질의 세균학적 분해에 관한 연구

(2006)홍길동 외 1명심리학41회 피인용

다운로드

2미국의 비트코인 규제

(2006)홍길동심리학41회 피인용

다운로드

가장 많이 참고한 논문

(자료제공: 네이버학술정보)

가장 많이 참고한 논문

다운로드

2미국의 비트코인 규제

(2006)홍길동41회 피인용

다운로드

해당 간행물 관심 구독기관

호남대학교 신구대학교 경남대학교 한림대학교 강동성심병원 질병관리본부
 24
 11
 9
 7
 6
  • 1 호남대학교 (24건)
  • 2 신구대학교 (11건)
  • 3 경남대학교 (9건)
  • 4 한림대학교 강동성심병원 (7건)
  • 5 질병관리본부 (6건)
  • 6 연세대학교 (6건)
  • 7 안동과학대학교 (6건)
  • 8 동의과학대학교 (5건)
  • 9 경희대학교 (5건)
  • 10 대전과학고등학교 (5건)

내가 찾은 최근 검색어

최근 열람 자료

맞춤 논문

보관함

내 보관함
공유한 보관함

1:1문의

닫기